The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

被引：0
|
作者：
Sundeep Singh
Shou-jiang Tang
Jayaprakash Sreenarasimhaiah
Luis F. Lara
Ali Siddiqui
机构：
[1] Stanford University,Division of Gastroenterology and Hepatology
[2] University of Mississippi,Division of Digestive Diseases
[3] University of Texas-Southwestern Medical Center,Division of Digestive and Liver Diseases
[4] Baylor University Medical Center,Division of Gastroenterology and Hepatology, Jefferson Digestive Disease Institute
[5] Thomas Jefferson University,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Serum carbohydrate antigen; CA19-9; Pancreatic cancer; Cholangiocarcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2491 / 2496
页数：5
相关论文
共 50 条
  • [1] The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
    Singh, Sundeep
    Tang, Shou-jiang
    Sreenarasimhaiah, Jayaprakash
    Lara, Luis F.
    Siddiqui, Ali
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2491 - 2496
  • [2] Predictive value of serum carbohydrate antigen 19-9 (CA19-9) for early mortality in advanced pancreatic cancer
    Junior P.L.S.U.
    Callegaro-Filho D.
    Bugano D.D.G.
    Moura F.
    Maluf F.C.
    Journal of Gastrointestinal Cancer, 2018, 49 (4) : 481 - 486
  • [3] Utility of serum CA19-9 in diagnosis of cholangiocarcinoma:In comparison with CEA
    Xing-Lei Qin Zuo-Ren Wang Jing-Sen Shi Lin Wang
    World Journal of Gastroenterology, 2004, (03) : 427 - 432
  • [4] Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA
    Qin, Xing-Lei
    Wang, Zuo-Ren
    Shi, Jing-Sen
    Lu, Min
    Wang, Lin
    He, Quan-Ru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (03) : 427 - 432
  • [5] THE DIAGNOSTIC SIGNIFICANCE OF CARBOHYDRATE ANTIGEN CA 19-9 IN SERUM AND PANCREATIC JUICE IN PANCREATIC CARCINOMA
    Chen Yuan-fang
    Mai Can-rong
    Tie Zhen-jun
    Feng Zi-tan
    Zhang Jie
    Lu Xing-hua
    Lu Guo-jun
    Xue You-hua
    Pan Guo-zong
    CHINESEMEDICALJOURNAL, 1989, (05)
  • [6] Serum CA19-9 determination in the management of pancreatic cancer
    vandenBosch, RP
    vanEijck, CHJ
    Mulder, PGH
    Jeekel, J
    HEPATO-GASTROENTEROLOGY, 1996, 43 (09) : 710 - 713
  • [7] Multimodality Neoadjuvant Therapy Increases Normalization of Carbohydrate Antigen 19-9 (CA19-9) in Patients with Pancreatic Cancer
    Krepline, A.
    Clarke, C. N.
    Christians, K.
    Ritch, P.
    George, B.
    Khan, A.
    Kulkarni, N.
    Hagen, C.
    Erickson, B.
    Hall, W.
    Aldakkak, M.
    Evans, D.
    Tsai, S.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S151 - S152
  • [8] Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer
    Karabulut, S.
    Ciftci, R.
    Sen, F.
    Tas, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S601 - S602
  • [9] Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9
    Tang, Huiyuan
    Partyka, Katie
    Hsueh, Peter
    Sinha, Jessica Y.
    Kletter, Doron
    Zeh, Herbert
    Huang, Ying
    Brand, Randall E.
    Haab, Brian B.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2 (02): : 210 - +
  • [10] Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9
    Ritchie, Shawn A.
    Chitou, Bassirou
    Zheng, Qingan
    Jayasinghe, Dushmanthi
    Jin, Wei
    Mochizuki, Asuka
    Goodenowe, Dayan B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (21) : 6604 - 6612
12345